Dexamethasone

Generic Name
Dexamethasone
Brand Names
Baycadron, Ciprodex, Decadron, Dexamethasone Intensol, Dextenza, Dioptrol, Hexadrol, Hidex 6-day Taper, Maxidex, Maxitrol, Neofordex, Ozurdex, Taperdex 12 Day Taper, Taperdex 6 Day Taper, Taperdex 7-day Taper, Tobradex, Zcort 7 Day Taper
Drug Type
Small Molecule
Chemical Formula
C22H29FO5
CAS Number
50-02-2
Unique Ingredient Identifier
7S5I7G3JQL
Background

Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Developed in 1957, it is structurally similar to other corticosteroids like hydrocortisone and prednisolone.
...

Indication

Dexamethasone and ciprofloxacin otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa. Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, an...

Associated Conditions
Acute Gouty Arthritis, Acute Leukemia, Acute Otitis Externa, Acute Otitis Media (AOM), Adrenocortical Hyperfunction, Adrenocortical Insufficiency, Allergic Conjunctivitis (AC), Alopecia Areata (AA), Ankylosing Spondylitis (AS), Aspiration Pneumonitis, Asthma, Atopic Dermatitis, Berylliosis, Bullous dermatitis herpetiformis, Bursitis, Chorioretinitis, Choroiditis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Conjunctivitis, Contact Dermatitis, Cushing's Syndrome, Dermatitis, Diabetic Macular Edema (DME), Discoid Lupus Erythematosus (DLE), Drug hypersensitivity reaction, Edema of the cerebrum, Epicondylitis, Episcleritis, Erythroblastopenia, Eye Infections, Eye allergy, Glaucoma, Hypercalcemia, Immune Thrombocytopenia (ITP), Infection, Inflammation, Inflammation of the External Auditory Canal, Intraocular Inflammation, Iridocyclitis, Iritis, Keloids Scars, Keratitis, Lichen Planus (LP), Lichen simplex chronicus, Loeffler's syndrome, Lymphoma, Macular Edema, Meningitis caused by Mycobacterium Tuberculosis, Middle ear inflammation, Mucosal Inflammation of the eye, Multiple Myeloma (MM), Muscle Inflammation caused by Cataract Surgery of the eye, Mycosis Fungoides (MF), Necrobiosis lipoidica diabeticorum, Non-infectious Posterior Uveitis, Ocular Infections, Irritations and Inflammations, Ocular Inflammation, Ocular Inflammation and Pain, Ocular Irritation, Ocular Itching, Ophthalmia, Sympathetic, Optic Neuritis, Otitis Externa, Pemphigus, Perennial Allergic Rhinitis (PAR), Phlyctenular keratoconjunctivitis, Postoperative Infections of the eyes caused by susceptible bacteria, Posttraumatic Osteoarthritis, Regional Enteritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile, Rosacea, Sarcoidosis, Scleritis, Seasonal Allergic Rhinitis, Secondary thrombocytopenia, Serum Sickness, Severe Seborrheic Dermatitis, Stevens-Johnson Syndrome, Synovitis, Systemic Lupus Erythematosus, Tenosynovitis, Trichinosis, Tuberculosis (TB), Ulcerative Colitis, Uveitis, Vernal Keratoconjunctivitis, Acquired immune hemolytic anemia, Acute rheumatic carditis, Anterior eye segment inflammation, Corticosteroid-responsive dermatoses, Ear infection-not otherwise specified caused by susceptible bacteria, Exfoliative erythroderma, Granuloma annulare lesions, Non-suppurative Thyroiditis, Ocular bacterial infections, Severe Psoriasis, Steroid-responsive inflammation of the eye, Swelling of the eyes, Varicella-zoster virus acute retinal necrosis, Watery itchy eyes
Associated Therapies
-

Evaluation of the Omission of Dexamethasone in Premedication Regimens During Paclitaxel Treatment

Phase 4
Not yet recruiting
Conditions
Interventions
First Posted Date
2023-11-07
Last Posted Date
2023-11-07
Lead Sponsor
Erasmus Medical Center
Target Recruit Count
500
Registration Number
NCT06118710
Locations
🇳🇱

Erasmus MC, Rotterdam, Zuid-Holland, Netherlands

A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)

First Posted Date
2023-10-27
Last Posted Date
2024-05-20
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
6
Registration Number
NCT06104449
Locations
🇯🇵

Yokohama City University Medical Center ( Site 0002), Yokohama, Kanagawa, Japan

🇯🇵

National Cancer Center Hospital East ( Site 0001), Kashiwa, Chiba, Japan

🇯🇵

Toho University Sakura Medical Center ( Site 0003), Sakura, Chiba, Japan

Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery

First Posted Date
2023-10-17
Last Posted Date
2024-01-23
Lead Sponsor
Poznan University of Medical Sciences
Target Recruit Count
90
Registration Number
NCT06086431
Locations
🇵🇱

Department of Spine Diseases and Pediatric Orthopedics, University of Medical Sciences, Poznań, Poland, Poznań, Wielkopolska, Poland

A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

First Posted Date
2023-10-16
Last Posted Date
2024-07-30
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
53
Registration Number
NCT06083922
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States

🇺🇸

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

🇺🇸

Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

and more 7 locations

Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade

First Posted Date
2023-10-12
Last Posted Date
2024-02-29
Lead Sponsor
Hubei Cancer Hospital
Target Recruit Count
98
Registration Number
NCT06080880
Locations
🇨🇳

Hubei Cancer Hospital, Wuhan, Hubei, China

Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma

First Posted Date
2023-09-22
Last Posted Date
2024-11-19
Lead Sponsor
Kathleen Dorritie
Target Recruit Count
34
Registration Number
NCT06050512
Locations
🇺🇸

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

Effect of Dexamethason on Postimplantation Syndrome After EVAR

First Posted Date
2023-09-21
Last Posted Date
2023-09-21
Lead Sponsor
Centro Hospitalar de Lisboa Central
Target Recruit Count
158
Registration Number
NCT06044480

Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population

First Posted Date
2023-09-18
Last Posted Date
2023-09-18
Lead Sponsor
University of Puerto Rico
Target Recruit Count
100
Registration Number
NCT06042426
Locations
🇵🇷

University of Puerto Ric-Dr. Federico Trilla Hospital, Carolina, Puerto Rico

Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.

Not Applicable
Not yet recruiting
Conditions
Interventions
First Posted Date
2023-09-15
Last Posted Date
2023-09-15
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
150
Registration Number
NCT06039280
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

© Copyright 2024. All Rights Reserved by MedPath